HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1506609Generated: November 1, 2026
HCID 16659853, compound → HCID 178517319, compound
https://huagongshe.com/reaction/1506609
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 16659853 | HCID 16659853 | — |
| Reactant | HCID 16659855 | HCID 16659855 | — |
| Reactant | HCID 178510096 | HCID 178510096 | — |
| Reactant | HCID 178517321 | HCID 178517321 | — |
| Product | HCID 178517319 | HCID 178517319 | — |
Reaction Steps
trans-3-[(8′-Chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quina-zolin]-5′-yl)oxy]cyclobutanecarboxylic acid; 3-[(8′-fluoro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinazolin]-5′-yl)oxymethyl]cyclobutanecarboxylic acid; trans-3-[(8′-cyano-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinaz-olin]-5′-yl)oxy]cyclobutanecarboxylic acid; 1-[(8′-fluoro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinazolin]-5′-yl)oxymethyl]cyclobutanecarboxylic acid; trans-3-[(8′-chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cycloheptyl-1,4′-quina-zolin]-5′-yl)oxy]cyclobutanecarboxylic acid; and trans-3-[(8′-chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclopentyl-1,4′-quinazolin]-5′-yl)oxy]cyclobutanecarboxylic acid; or a pharmaceutically acceptable salt, solvate, polymorph or prodrug thereof.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09220715B2 |
|---|
| Source dataset | uspto-grants-2015_12 |
|---|
| ORD ID | ord-13afd7ace3cf4a28b0cee30de8814d8e |
|---|
| Source note | uspto-grants-2015_12 |
|---|